Prof. Young has served as a consultant to Johnson and Johnson, Livanova, and South London and Maudsley Trust; he has served as a paid lecturer and advisory board member for Allegan, AstraZeneca, Bionomics, Eli Lilly, Janssen, Livanova, Lundbeck, Servier, Sumitomo Dainippon Pharma, and Sunovion; he has served as principal investigator for trials supported by LivaNova; and he has received grant funding from the British Medical Association, Canadian Institutes of Health Research, Janssen, the Medical Research Council (UK), the Michael Smith Foundation for Health Research (Canada), NARSAD, National Institute for Health Research (UK), NIMH, Royal College of Physicians (Edinburgh), Stanley Medical Research Institute, VGH and UBC Hospital Foundation (Canada), WEDC (Canada), and Wellcome Trust. Dr. Gottlieb reports no financial relationships with commerical interests.